Why the study?
Human Mx1 prevents zoonotic virus transmissions, prompting evaluation of the antiviral activity of other mammalian Mx1 proteins against Thogoto virus.
Equine Mx1 possesses unique antiviral activity against Thogoto virus among nonhuman mammalian Mx1 proteins, determined by specific residues in the L4 loop.
EqMx1 uniquely restricts Thogoto virus via L4 residues; hypothesis-generating for Mx1 engineering in antiviral research.
Most mammals encode two paralogs of the interferon-induced Mx proteins: Mx1, with antiviral activity largely against RNA viruses, like orthomyxoviruses and bunyaviruses; and Mx2, which is antivirally active against HIV-1 and herpesviruses. The human Mx1 protein, also called huMxA, is the best-characterized example of mammalian Mx1 proteins and was recently shown to prevent zoonotic virus transmissions. To evaluate the antiviral activity of other mammalian Mx1 proteins, we used Thogoto virus, a tick-transmitted orthomyxovirus, which is efficiently blocked by huMxA. Interestingly, we detected antiviral activity only with equine Mx1 (eqMx1) but not with other nonprimate Mx1 proteins. Detailed functional analysis of eqMx1 identified amino acid residues in the unstructured loop L4 of the stalk domain critical for antiviral activity. The structural insights of the present study explain the unique position of eqMx1 antiviral activity within the collection of nonhuman mammalian Mx1 proteins.
No takes yet. Share an insight, caveat, or question.
Wagner et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: